Scil Proteins GmbH / Navigo Proteins

Activities: Manufacturing Ingredients Research & Development Pharmaceutical

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. Overcoming CMC challenges in cell and gene therapy: part I Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
  3. Resolving capping issues in tablet manufacturing Natoli explores the various causes of capping and the methods to prevent it
  4. Effective ways to optimise heat exchangers Heat exchangers are used within a wide range of process industries as a way to transfer heat between two fluid streams across a medium in an energy conservative way
  5. Transforming healthcare with patient centricity In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

Related Content

Media

UV-Cap acquires 100% shares of Scil Proteins

Scil Proteins is acquired from Bionet Ventures and renamed Navigo Proteins
Research & Development

ITM and Scil Proteins agree targeted radio conjugates partnership

German firms will develop targeted radio conjugates for imaging and therapy purposes, in a variety of indications
Manufacturing

Wacker acquires Scil Proteins Production

The transaction will create a leading microbial-based biopharmaceutical manufacturer
Ingredients

Scil Proteins receives EMA approval for commercial production of Reteplase

The recombinant protein will be produced in Halle, Germany
Research & Development

Rainer-Rudolph-Foundation acknowledges outstanding research

Awards three prizes to young researchers in the fields of protein biochemistry and biotechnology
Ingredients

Scil Proteins establishes business development organisation in California

To be headed by Garry Merry
Pharmaceutical

Call for entries to Rainer Rudolph Foundation prizes

Closing date is 31 March
Subscribe now